Zobrazeno 1 - 10
of 43
pro vyhledávání: '"J Azzahhafi"'
Autor:
N M R Van Der Sangen, J Azzahhafi, D R P P Chan Pin Yin, E E Torunogullari, J M Ten Berg, J P S Henriques, W J Kikkert
Publikováno v:
European Heart Journal. 43
Background Radial crossover and unsuccessful radial access during coronary angiography or percutaneous coronary intervention (PCI) are associated with worse outcomes compared to successful radial access. The MATRIX score estimates the risk of radial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::caf5bc53b2ae35b030b5c799ea9155c9
https://doi.org/10.1093/eurheartj/ehac544.2049
https://doi.org/10.1093/eurheartj/ehac544.2049
Autor:
W L Bor, J Azzahhafi, N Di Maio, N M R Van Der Sangen, S Rayhi, D R P P Chan Pin Yin, J Peper, J M Ten Berg
Publikováno v:
European Heart Journal. 43
Background/Introduction Newly diagnosed atrial fibrillation (AF) frequently occurs during acute coronary syndrome (ACS). In contrast to known AF, little is known about the prognostic and therapeutic implications of new AF. Purpose To evaluate the pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::316db7f073bac9a72f75b4a9be377c31
https://doi.org/10.1093/eurheartj/ehac544.1329
https://doi.org/10.1093/eurheartj/ehac544.1329
Publikováno v:
Cardiovascular Research. 118
Background The CYP2C9-enzym plays a role in the metabolization of clopidogrel. In patients treated with clopidogrel, carriage of a CYP2C9 loss-of-function (LoF) allele has been associated with attenuated pharmacokinetics leading to a diminished pharm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::784a18c60b4e97b00c347d677d5f0151
https://doi.org/10.1093/cvr/cvac157.058
https://doi.org/10.1093/cvr/cvac157.058
Autor:
D Chan Pin Yin, J Azzahhafi, S Rayhi, J Peper, N M R Van Der Sangen, R M Tjon Joe Gin, D M Nicastia, R Walhout, J Langerveld, W L Bor, G J A Vos, J P S Henriques, W J Kikkert, J M Ten Berg
Publikováno v:
European Heart Journal. 43
Background Contemporary real-world data on conservatively managed patients with acute coronary syndrome (ACS) is scarce. Objective To evaluate conservative management compared with revascularization therapy in ACS patients, focused on ischemic and bl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcd90dbd9844c03e285e0a0caae5221c
https://doi.org/10.1093/eurheartj/ehac544.1375
https://doi.org/10.1093/eurheartj/ehac544.1375
Publikováno v:
Cardiovascular Research. 118
Background/rationale Newly diagnosed atrial fibrillation(AF) during acute coronary syndrome(ACS) is associated with worse outcomes. In this study we evaluated the associated stroke risk of newly diagnosed AF in ACS patients according to the onset and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a9a2b70c7d9323f39335ec9c98487e3
https://doi.org/10.1093/cvr/cvac157.113
https://doi.org/10.1093/cvr/cvac157.113
Autor:
J Azzahhafi, T O Bergmeijer, W W A Van Den Broek, D R P P Chan Pin Yin, S Rayhi, J Peper, W L Bor, R H N Van Schaik, J M Ten Berg
Publikováno v:
European Heart Journal. 43
Background Current guidelines recommend using ticagrelor in patients with acute coronary syndrome. Ticagrelor is predominantly metabolized by CYP3A4 and to a lesser extent by CYP3A5. CYP3A4*22 allele and the CYP3A5 expressor status influence the meta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2e9d128f26b2e8fddc61bf95f2f05e8
https://doi.org/10.1093/eurheartj/ehac544.1230
https://doi.org/10.1093/eurheartj/ehac544.1230
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M.C. Post, M. J. Swaans, F Akdim, A.L.M. Bakker, J. Azzahhafi, Jan C. Grutters, Marcel Veltkamp, R.G.M. Keijsers, Harold Mathijssen
Publikováno v:
International journal of cardiology. 330
Background Immunosuppressive therapy in active cardiac sarcoidosis (CS) might prevent potential life-threatening complications. Infliximab (IFX) is a tumor necrosis factor alpha monoclonal antibody proven to be effective in refractory extracardiac sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1451507f80d679525bd81e8f71b8e7d4
https://pubmed.ncbi.nlm.nih.gov/33582196
https://pubmed.ncbi.nlm.nih.gov/33582196
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.